Yousif Capital Management LLC Has $1.21 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Yousif Capital Management LLC lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 1.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 52,628 shares of the company’s stock after acquiring an additional 563 shares during the period. Yousif Capital Management LLC’s holdings in Privia Health Group were worth $1,212,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in PRVA. New York State Common Retirement Fund grew its position in Privia Health Group by 61.3% during the 4th quarter. New York State Common Retirement Fund now owns 45,100 shares of the company’s stock worth $1,039,000 after purchasing an additional 17,134 shares in the last quarter. Illinois Municipal Retirement Fund grew its holdings in shares of Privia Health Group by 9.7% during the fourth quarter. Illinois Municipal Retirement Fund now owns 59,828 shares of the company’s stock valued at $1,378,000 after buying an additional 5,272 shares in the last quarter. Handelsbanken Fonder AB raised its position in Privia Health Group by 41.5% during the fourth quarter. Handelsbanken Fonder AB now owns 15,000 shares of the company’s stock valued at $345,000 after buying an additional 4,400 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Privia Health Group by 6.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 22,089 shares of the company’s stock worth $509,000 after acquiring an additional 1,260 shares in the last quarter. Finally, Louisiana State Employees Retirement System acquired a new stake in Privia Health Group during the 4th quarter worth about $1,184,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Insider Transactions at Privia Health Group

In related news, EVP Thomas Bartrum sold 2,252 shares of the firm’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total value of $41,481.84. Following the transaction, the executive vice president now directly owns 103,862 shares in the company, valued at approximately $1,913,138.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Privia Health Group news, EVP Thomas Bartrum sold 2,252 shares of the company’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total transaction of $41,481.84. Following the completion of the sale, the executive vice president now directly owns 103,862 shares in the company, valued at $1,913,138.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Parth Mehrotra sold 12,219 shares of the firm’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total value of $225,073.98. Following the completion of the sale, the chief executive officer now directly owns 261,640 shares in the company, valued at $4,819,408.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 31,783 shares of company stock worth $582,886. 14.20% of the stock is owned by insiders.

Analyst Ratings Changes

PRVA has been the topic of a number of research reports. Barclays assumed coverage on Privia Health Group in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $22.00 target price on the stock. Truist Financial cut their target price on shares of Privia Health Group from $32.00 to $28.00 and set a “buy” rating for the company in a research report on Thursday, February 29th. JPMorgan Chase & Co. lowered their price target on shares of Privia Health Group from $38.00 to $30.00 and set an “overweight” rating on the stock in a report on Wednesday, March 6th. TD Cowen cut their price objective on Privia Health Group from $30.00 to $26.00 and set an “outperform” rating for the company in a report on Friday, March 1st. Finally, Bank of America downgraded Privia Health Group from a “buy” rating to a “neutral” rating and lowered their target price for the company from $27.00 to $21.00 in a research note on Thursday, February 22nd. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $27.62.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $18.74 on Friday. The stock has a market capitalization of $2.22 billion, a P/E ratio of 98.64, a P/E/G ratio of 2.46 and a beta of 0.81. The business has a 50-day moving average of $19.64 and a two-hundred day moving average of $21.14. Privia Health Group, Inc. has a fifty-two week low of $17.54 and a fifty-two week high of $30.15.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). The company had revenue of $440.80 million during the quarter, compared to the consensus estimate of $425.81 million. Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. The firm’s revenue was up 21.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.14 earnings per share. As a group, research analysts expect that Privia Health Group, Inc. will post 0.26 EPS for the current fiscal year.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.